Have a feature idea you'd love to see implemented?
Let us know!
VERA Vera Therapeutics Inc
Price (delayed)
$47.03
Market cap
$2.98B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.61
Enterprise value
$3.01B
Highlights
VERA's equity has soared by 134% year-on-year but it is down by 12% since the previous quarter
The quick ratio has soared by 105% YoY but it has contracted by 36% from the previous quarter
VERA's debt has soared by 86% year-on-year and by 3.9% since the previous quarter
The net income has contracted by 31% YoY and by 25% from the previous quarter
Key stats
What are the main financial stats of VERA
Market
Valuations
Earnings
Shares outstanding
63.32M
Market cap
$2.98B
Enterprise value
$3.01B
Price to earnings (P/E)
N/A
Price to book (P/B)
8.92
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$127.57M
EBITDA
-$126.64M
Free cash flow
-$121.03M
Per share
Balance sheet
Liquidity
EPS
-$2.61
Free cash flow per share
-$2.2
Book value per share
$5.27
Revenue per share
$0
TBVPS
$6.71
Total assets
$368.56M
Total liabilities
$79.5M
Debt
$54.91M
Equity
$289.06M
Working capital
$337.67M
Debt to equity
0.19
Current ratio
13.76
Quick ratio
13.35
Net debt/EBITDA
-0.22
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-39.5%
Return on equity
-50.1%
Return on invested capital
-38.5%
Return on capital employed
-37.3%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
VERA stock price
How has the Vera Therapeutics stock price performed over time
Intraday
2.8%
1 week
-4.02%
1 month
15.02%
1 year
247.6%
YTD
205.79%
QTD
6.4%
Financial performance
How have Vera Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$145.28M
Net income
-$134.38M
Gross margin
N/A
Net margin
N/A
VERA's operating income is down by 34% year-on-year and by 24% since the previous quarter
The net income has contracted by 31% YoY and by 25% from the previous quarter
Growth
What is Vera Therapeutics's growth rate over time
Valuation
What is Vera Therapeutics stock price valuation
P/E
N/A
P/B
8.92
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
VERA's EPS is down by 18% since the previous quarter but it is up by 10% year-on-year
VERA's equity has soared by 134% year-on-year but it is down by 12% since the previous quarter
VERA's P/B is 29% more than its last 4 quarters average of 6.9
Efficiency
How efficient is Vera Therapeutics business performance
The ROIC has soared by 53% YoY but it has contracted by 4.6% from the previous quarter
VERA's return on equity is up by 39% year-on-year but it is down by 5% since the previous quarter
The ROA has increased by 32% year-on-year but it has declined by 7% since the previous quarter
Dividends
What is VERA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for VERA.
Financial health
How did Vera Therapeutics financials performed over time
VERA's total assets has surged by 110% year-on-year but it is down by 7% since the previous quarter
The quick ratio has soared by 105% YoY but it has contracted by 36% from the previous quarter
VERA's debt is 81% smaller than its equity
VERA's equity has soared by 134% year-on-year but it is down by 12% since the previous quarter
VERA's debt has soared by 86% year-on-year and by 3.9% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.